Hlobilková A - Search Results

1

Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines.

Mad'arová J, Lukesová M, Hlobilková A, Strnad M, Vojtesek B, Lenobel R, Hajdúch M, Murray PG, Perera S, Kolár Z. Mad'arová J, et al. Among authors: hlobilkova a. Mol Pathol. 2002 Aug;55(4):227-34. doi: 10.1136/mp.55.4.227. Mol Pathol. 2002. PMID: 12147712 Free PMC article.

2

The effects of natural ligands of hormone receptors and their antagonists on telomerase activity in the androgen sensitive prostatic cancer cell line LNCaP.

Bouchal J, Kolár Z, Mad'arová J, Hlobilková A, von Angerer E. Bouchal J, et al. Among authors: hlobilkova a. Biochem Pharmacol. 2002 Mar 15;63(6):1177-81. doi: 10.1016/s0006-2952(01)00927-3. Biochem Pharmacol. 2002. PMID: 11931851

3

Differences in p53 and Bcl-2 expression in relation to cell proliferation during the development of human embryos.

Lichnovský V, Kolár Z, Murray P, Hlobilková A, Cernochová D, Pospísilová E, Vojtĕsek B, Nenutil R. Lichnovský V, et al. Among authors: hlobilkova a. Mol Pathol. 1998 Jun;51(3):131-7. doi: 10.1136/mp.51.3.131. Mol Pathol. 1998. PMID: 9850335 Free PMC article.

4

Androgen sensitivity related proteins in hormone-sensitive and hormone-insensitive prostate cancer cell lines treated by androgen antagonist bicalutamide.

Madarová J, Lukesová M, Hlobilková A, Riháková P, Murray PG, Student V, Vojtsek B, Kolár Z. Madarová J, et al. Among authors: hlobilkova a. Neoplasma. 2001;48(5):419-24. Neoplasma. 2001. PMID: 11845989

5

Synergic effects of the cyclin-dependent kinase (CDK) inhibitor olomoucine and androgen-antagonist bicalutamide on prostatic cancer cell lines.

Knillová J, Bouchal J, Hlobilková A, Strnad M, Kolár Z. Knillová J, et al. Among authors: hlobilkova a. Neoplasma. 2004;51(5):358-67. Neoplasma. 2004. PMID: 15640940

6

The significance of key regulators of apoptosis in the development and prognosis of prostate carcinoma. II. Products of suppressor genes Rb and PTEN, CDKI, Fas.

Knillová J, Kolár Z, Hlobilková A. Knillová J, et al. Among authors: hlobilkova a. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2003 Nov;147(1):11-7. doi: 10.5507/bp.2003.002. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2003. PMID: 15034600 Review.

7

Induction of apoptosis and regression of spontaneous dog melanoma following in vivo application of synthetic cyclin-dependent kinase inhibitor olomoucine.

Hajdúch M, Kolár Z, Novotný R, Hanus J, Mihál V, Hlobílková A, Nosková V, Strnad M. Hajdúch M, et al. Among authors: hlobilkova a. Anticancer Drugs. 1997 Nov;8(10):1007-13. doi: 10.1097/00001813-199711000-00012. Anticancer Drugs. 1997. PMID: 9436644

8

Nuclear receptors in early hormone refractory prostate cancer and their relationship to apoptosis-related proteins.

Kolár Z, Murray PG, Madarova J, Lukesova M, Hlobilkova A, Riháková P, Flavell P, Strnad M, Student V, Vojtesek B. Kolár Z, et al. Among authors: hlobilkova a. Neoplasma. 2002;49(3):172-7. Neoplasma. 2002. PMID: 12098003

9

Tumour suppressor PTEN regulates cell cycle and protein kinase B/Akt pathway in breast cancer cells.

Hlobilkova A, Knillova J, Svachova M, Skypalova P, Krystof V, Kolar Z. Hlobilkova A, et al. Anticancer Res. 2006 Mar-Apr;26(2A):1015-22. Anticancer Res. 2006. PMID: 16619501 Free article.

10

Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?

Hlobilkova A, Ehrmann J, Sedlakova E, Krejci V, Knizetova P, Fiuraskova M, Kala M, Kalita O, Kolar Z. Hlobilkova A, et al. Neoplasma. 2007;54(4):334-41. Neoplasma. 2007. PMID: 17822324

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters